Patent · US Active

Methods for determining signal transduction activity in tumors

US8367351B2 · kind B2 · utility

1Cited by
20References
17Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMay 7, 2007
Grant dateFeb 5, 2013
Priority date
Expiry dateApr 9, 2029

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T436/10
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The method of the invention pertains to determining the signal transduction activity in a tissue section by immunohistochemistry techniques. The expression level of the receptor of interest is determined as well as the expression levels of one or more effector molecules of the receptor signal transduction pathway. Furthermore a combined ratio of expression levels of effector molecules in subcellular compartments with the receptor expression was found to have prognostic significance.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.